Sandu Pharmaceuticals Ltd.
| BSE: 524703 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE751D01014 |
| BSE 15:09 | 04 Mar | 30.00 |
-0.55 (-1.80%) |
OPEN
29.55 |
HIGH
30.40 |
LOW
29.00 |
| NSE 05:30 | 01 Jan | Sandu Pharmaceuticals Ltd |
| OPEN | 29.55 |
| PREVIOUS CLOSE | 30.55 |
| VOLUME | 2890 |
| 52-Week high | 43.70 |
| 52-Week low | 10.45 |
| P/E | 23.81 |
| Mkt Cap.(Rs cr) | 21 |
| Buy Price | 30.00 |
| Buy Qty | 100.00 |
| Sell Price | 30.40 |
| Sell Qty | 50.00 |
Sandu Pharmaceuticals Ltd. (SANDUPHARMA) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 619.75 | -0.70 | 653.70 | 315.20 | 148696.61 |
| Divi's Lab. | 3549.35 | -0.44 | 3913.00 | 1632.70 | 94217.50 |
| Dr Reddy's Labs | 4567.25 | 1.48 | 5514.65 | 2497.60 | 75953.37 |
| Cipla | 808.00 | -0.53 | 878.55 | 356.75 | 65161.16 |
| Aurobindo Pharma | 875.00 | -0.66 | 1023.10 | 281.15 | 51266.25 |
| Biocon | 399.50 | -0.82 | 487.70 | 235.80 | 47940.00 |
| Lupin | 1046.50 | -1.35 | 1121.85 | 505.00 | 47474.47 |
| Cadila Health. | 448.80 | 0.74 | 509.35 | 212.70 | 45943.66 |
| Piramal Enterp. | 1952.45 | -2.02 | 2008.20 | 608.00 | 44037.51 |
| Apollo Hospitals | 3036.60 | -0.70 | 3283.90 | 1047.45 | 43660.23 |
| Gland Pharma | 2658.75 | 9.29 | 2692.00 | 1701.00 | 43470.56 |
| Torrent Pharma. | 2490.00 | -0.30 | 3040.00 | 1619.00 | 42135.78 |
| Alkem Lab | 2828.10 | -0.45 | 3150.00 | 1950.00 | 33809.94 |
| Abbott India | 14709.05 | 0.68 | 18569.00 | 12500.00 | 31256.73 |
| Glaxosmi. Pharma | 1544.40 | 1.31 | 1805.00 | 1046.40 | 26163.68 |
| Ipca Labs. | 1938.00 | -1.19 | 2455.55 | 1162.00 | 24583.53 |
| Syngene Intl. | 550.95 | -0.03 | 644.65 | 201.65 | 22038.00 |
| Pfizer | 4615.50 | -0.68 | 5875.00 | 3588.15 | 21115.91 |
| Laurus Labs | 367.95 | 0.92 | 385.80 | 61.90 | 19744.20 |
| Dr Lal Pathlabs | 2347.00 | 0.92 | 2626.30 | 1181.80 | 19559.90 |
Quick Links for Sandu Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
